{"tid":2324938,"cid":5,"subCid":0,"title":"購買疫苗777又輸左比10%","createTime":"2020-12-14T10:03:55.000Z","updateTime":"2020-12-14T10:13:49.000Z","uid":224659,"like":1,"dislike":1,"uniUserReply":2,"replies":[{"pid":"60e37d6efa7cb3dfb75bb027e42f0cb989c2c999","tid":2324938,"uid":224659,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-14T10:03:55.000Z","msg":"本澳新冠肺炎疫苗的採購進展，傳染病防制暨疾病監測部協調員梁亦好表示，政府早於今年3月開始已接觸疫苗廠家，直接和三種研發進度較快的疫苗生產公司洽談。其後，於今年7月參加WHO-GAVI(全球疫苗接種聯盟)的COVAX機制(全球新冠病毒疫苗保障計劃)，以及於9月簽署了COVAX(全球新冠病毒疫苗保障計劃)協議，採購20萬劑，並繳交了訂金。預期COVAX機制供應的疫苗會在2021年第四季開始供應。<br />\n<br />\n政府計劃購入三種來自不同產地的疫苗，各採購40萬劑（不包括GAVI計劃的20萬劑）。<br />\n<br />\n🔸1️⃣國藥集團，滅活疫苗，產地北京，明年第一季<br />\n🔹2️⃣復星代理，BioNtech，mRNA疫苗，產地德國、法國或比利時，明年第一季<br />\n🔸3️⃣AstraZeneca代理，牛津腺病毒載體疫苗，產地美國，明年第二季<br />\n<img src=\"https://na.cx/i/MWhmNpa.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fna.cx%2Fi%2FMWhmNpa.jpg&h=0e8b9771&s={SIZE}\" />"},{"pid":"6a82a0dfabd4d8ceaee8236d8b55d6717a7093b2","tid":2324938,"uid":246156,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-12-14T10:13:49.000Z","msg":"馬交好似有得揀打邊隻？"}]}